Authors:
DEJAEGERE P
MUDRA H
FIGULLA H
ALMAGOR Y
DOUCET S
PENN I
COLOMBO A
HAMM C
BARTORELLI A
ROTHMAN M
NOBUYOSHI M
YAMAGUCHI T
VOUDRIS V
DIMARIO C
MAKOVSKI S
HAUSMANN D
ROWE S
RABINOVICH S
SUNAMURA M
VANES GA
Citation: P. Dejaegere et al., INTRAVASCULAR ULTRASOUND-GUIDED OPTIMIZED STENT DEPLOYMENT - IMMEDIATE AND 6 MONTHS CLINICAL AND ANGIOGRAPHIC RESULTS FROM THE MULTICENTER ULTRASOUND STENTING IN CORONARIES STUDY (MUSIC STUDY), European heart journal, 19(8), 1998, pp. 1214-1223
Authors:
LEFEVRE T
MORICE MC
GARCIA E
KIEMENEY F
PIEPER M
MACAYA C
VANES GA
MATTOS L
GRINES C
Citation: T. Lefevre et al., PREDICTIVE FACTORS OF SUBOPTIMAL FLOW AFTER PRIMARY PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY IN ACUTE MYOCARDIAL-INFARCTION - RESULTSFROM THE STENT PAMI RANDOMIZED STUDY, Circulation, 98(17), 1998, pp. 782-782
Authors:
SERRUYS PW
UNGER F
VANHERWERDEN L
MOHR F
SIMON R
ALBRECHTS C
WIJNS W
VANHOUT B
VANES GA
HUGENHOLTZ PG
MOREL MA
Citation: Pw. Serruys et al., ARTERIAL REVASCULARIZATION THERAPY STUDY - THE ARTS STUDY, A RANDOMIZED TRIAL OF BYPASS-SURGERY VERSUS STENTING IN MULTIVESSEL CORONARY-DISEASE, Circulation, 98(17), 1998, pp. 2620-2620
Authors:
MOONS KGM
VANES GA
DECKERS JW
HABBEMA JDF
GROBBEE DE
Citation: Kgm. Moons et al., LIMITATIONS OF SENSITIVITY, SPECIFICITY, LIKELIHOOD RATIO, AND BAYES THEOREM IN ASSESSING DIAGNOSTIC PROBABILITIES - A CLINICAL EXAMPLE, Epidemiology, 8(1), 1997, pp. 12-17
Authors:
MOONS KGM
VANES GA
DECKERS JW
HABBEMA JDF
GROBBEE DE
Citation: Kgm. Moons et al., LIMITATIONS OF SENSITIVITY, SPECIFICITY, LIKELIHOOD RATIO, AND BAYES THEOREM IN ASSESSING DIAGNOSTIC PROBABILITIES - A CLINICAL EXAMPLE, Epidemiology, 8(1), 1997, pp. 12-17
Authors:
SERRUYS PW
BANZ K
DARCIS T
MIGNOT A
VANES GA
SCHWICKER D
Citation: Pw. Serruys et al., RESULTS OF A METAANALYSIS OF TRAPIDIL, A PDGF INHIBITOR - A SUFFICIENT REASON FOR A 2ND-LOOK TO THE PHARMACOLOGICAL APPROACH TO RESTENOSIS, The Journal of invasive cardiology, 9(8), 1997, pp. 505-512
Authors:
MOONS CKGM
VANES GA
STIJNEN T
BAK AAA
HOFMAN A
JONKER JJC
HABBEMA JDF
GROBBEE DE
Citation: Ckgm. Moons et al., EFFICIENCY OPTIMIZATION OF THE SELECTION PERIOD IN THERAPEUTIC TRIALS, Journal of clinical epidemiology, 50(7), 1997, pp. 793-800
Authors:
FRANKE CL
KOEHLER PJJ
GORTER JW
KAPPELLE LJ
RINKEL GJE
TJEERDSMA HC
VANGIJN J
DAMMERS JWHH
STRAATMAN HJS
TENHOUTEN R
VEERING MM
BAKKER SLM
DIPPEL D
KOUDSTAAL PJ
VANGEMERT HMA
VANSWIETEN JC
HORN J
KWA IH
LIMBURG M
STAM J
BOON AM
LIEUWENS WHG
VISSCHER F
BOUWSMA C
RUTGERS AWF
SNOEK JW
BROUWERS PJAM
NIHOM J
SOLLEVELD H
CARBAAT PAT
HERTZBERGER LI
KLEIJWEG RP
NANNINGAVANDENNESTE VMH
VANDIEPEN AJH
LINSSEN WHJP
VANNESTE JAL
VOS J
WEINSTEIN HC
SCHIPPER JP
VANDERMEER WK
BERNTSEN PJIM
DEVRIESLEENDERS EM
GEERVLIET JP
TANS RJJ
FEIKEMA WJ
LOHMANN HJHM
VANKASTEEL V
JONGEBLOED FA
LEYTEN QH
VANWENSEN PJM
JANSEN C
SMITS MG
DRIESEN JJM
VANOUDENAARDEN WF
VERHEY JCB
BOTTGER HRF
DRIESSENKLETTER MF
ZWOLS F
VANDERGAAST JB
WITTEBOL MC
LODDER J
VANOOSTENBRUGGE RJ
BEINTEMA KD
HILBERS J
VANDERWEIL HL
VANLIESHOUT HBM
WESTSTRATE W
BERNSEN PLJA
FRENKEN CWGM
POELS EFJ
LINDEBOOM SF
VANDERSTEEN A
GLIMMERVEEN WF
MARTENS EIF
BULENS C
DEVRIESBOS LHP
VENABLES GS
KOSTER JG
SINNIGE LGF
KLAVER MM
KOETSVELDBAART JC
MAUSER HW
DON JA
VANGEUSAU RBA
DIJKMAN MH
HOPPENBROUWERS WJJF
BANFORD WJJF
BRIET PE
EEKHOF JLA
WITJES R
HAMBURGER HL
VANDERSANDE JJ
BATH P
HANKEY GJ
KONING E
RICCI S
BERENDES JN
HOOFF LJMA
VANSPREEKEN ACGA
WOUTERS HNA
KUHLER AR
MALLO GN
VANWALBEEK HK
GAUW JC
VERMEIJ AJ
VERHEIJ JCB
SWEN JWA
CANHAO P
KEYSER A
HOLSCHER RS
DEJONG GJ
KRAAIER V
AGRA A",BRIETE,"DEVRIESGOLDSCHEMDINGI J
EIKELBOOM BC
GREEBE P
HAUER RNW
HERMSEN MG
LOELIGER EA
POP GAM
ROSENDAAL FR
SCHOBBEN AFAM
SIMOONS ML
SIXMA FF
SLABBERS DCV
TIJSSEN JCP
VANCREVAL H
VANES GA
VERHEUGT FWA
VERMEULIN M
WEVER EFD
WULFSEN EKM
Citation: Cl. Franke et al., A RANDOMIZED TRIAL OF ANTICOAGULANTS VERSUS ASPIRIN AFTER CEREBRAL-ISCHEMIA OF PRESUMED ARTERIAL ORIGIN, Annals of neurology, 42(6), 1997, pp. 857-865
Authors:
MOONS KGM
VANES GA
MICHEL BC
BULLER HR
HABBEMA JDF
GROBBEE DE
Citation: Kgm. Moons et al., HAZARDS OF AN UNIVARIATE APPROACH IN THE COMPARISON OF 3 TESTS TO DIAGNOSE PULMONARY-EMBOLISM, Thrombosis and haemostasis, 1997, pp. 2898-2898
Authors:
MOONS KGM
STIJNEN T
MICHEL BC
BULLER HR
VANES GA
GROBBEE DE
HABBEMA JDF
Citation: Kgm. Moons et al., APPLICATION OF TREATMENT THRESHOLDS TO DIAGNOSTIC-TEST EVALUATION - AN ALTERNATIVE TO THE COMPARISON OF AREAS UNDER RECEIVER OPERATING CHARACTERISTIC CURVES, Medical decision making, 17(4), 1997, pp. 447-454
Authors:
VANDERWERF F
VAHANIAN A
GULBA DC
MULLER J
ARNOLD AER
BAR F
VERMEER F
VERHEUGT FWA
BOERSMA H
VANES GA
DECKERS JW
LENDERINK T
SIMOONS ML
STEYERBERG E
VANDERZWAAN C
DEBOER MJ
ZIJLSTRA F
WILCOX RD
SLEIGHT P
SELKER HP
CALIFF RM
GRANGER C
LEE KL
OHMAN ME
WEAVER DW
LOVE T
WHITE H
CALIFF R
COLLINS R
Citation: F. Vanderwerf et al., SELECTION OF REPERFUSION THERAPY FOR INDIVIDUAL PATIENTS WITH EVOLVING MYOCARDIAL-INFARCTION, European heart journal, 18(9), 1997, pp. 1371-1381
Authors:
DEJONGE R
MACLEOD DC
SURYAPRANATA H
VANES GA
FRIEDMAN J
SERRUYS PW
DEJONG JW
Citation: R. Dejonge et al., EFFECT OF ACADESINE ON MYOCARDIAL-ISCHEMIA IN PATIENTS WITH CORONARY-ARTERY DISEASE, European journal of pharmacology, 337(1), 1997, pp. 41-44
Authors:
LENDERINK T
SIMOONS ML
VANES GA
VANDEWERF F
VERSTRAETE M
ARNOLD AER
Citation: T. Lenderink et al., BENEFIT OF THROMBOLYTIC THERAPY TS SUSTAINED THROUGHOUT 5 YEARS AND IS RELATED TO TIMI PERFUSION GRADE 3 BUT NOT GRADE 2 FLOW AT DISCHARGE, Circulation, 92(5), 1995, pp. 1110-1116
Authors:
BOTS ML
MULDER PGH
HOFMAN A
VANES GA
GROBBEE DE
Citation: Ml. Bots et al., REPRODUCIBILITY OF CAROTID VESSEL WALL THICKNESS MEASUREMENTS - THE ROTTERDAM STUDY, Journal of clinical epidemiology, 47(8), 1994, pp. 921-930
Authors:
JONKER JJC
VANBERGEN PFMM
VANDERMEER FJM
AZAR AJ
MEETER K
DECKERS JW
COLLY LP
TIJSSEN JGP
VANAKEN WG
DUNNING AJ
HOFMAN A
HUGENHOLTZ PG
VANDERKOOIJ S
LOELIGER EA
LUBSEN J
MEADE TW
VANDERMEER J
MIETTINEN OS
MITCHELL JRA
MUSTARD JF
PIETERS JJL
VANSTRIK R
VERHEUGT FWA
VERSTRAETE M
VIERSMA JW
VANZWIETEN PA
VANES GA
VANSTRIK P
VANZWIETEN PA
BECKER AE
VANDEBURGH PH
DEGRAEFF JJ
KOUDSTAAL PJ
MOLHOEK GP
DENEELING A
DENOTTOLANDER GJ
VANREES C
WINTZEN AR
ADMIRAAL J
ANTHEUNISSEN IM
BEINEMA MJ
VANBEUSEKOM WI
BOLWEGWAAGE MM
BREUKINKENGBERS WGM
BROEKMANS AW
CHIN H
VANDAM FE
VANDOMBURG RT
GERRITSDRABBE CW
VANGEESTDAALDEROP J
GEVENBOERE LM
HANNIVOORT EJW
HILLEN PH
HEERE FJ
HOLDRINET AC
JELETICHBASTIAANSE A
KIERS GJ
KOUSEMAKER AC
VANMEEGEN E
PIERSMA G
ROMMENS CAW
SCHAAP RC
VANDERVEUR E
VRIESGOLDSCHMEDING J
MEULENBELT F
VANDERBREDA BM
DUCHATEAU AMJA
ENGELBERTS P
BRENNINKMEYER VJ
DAGNEAUX PGLCK
VOS T
VERMEIJ P
BRANDENBURG HCR
DUIJNE C
GRAATSMA BH
LENDERINK AW
RUTTEN JJMH
HARTING J
SMITH TJ
VANDERVEEN D
VANDERBERGH D
DIJKSHOORN A
EIGENRAM P
DEJONG JD
KENSENHUIS IM
MAHLER CCE
VANDERSMAN AJ
VISSER HC
WIELDERS L
DEBEER YAJ
SPEELMAN M
OEI S
Citation: Jjc. Jonker et al., EFFECT OF LONG-TERM ORAL ANTICOAGULANT TREATMENT ON MORTALITY AND CARDIOVASCULAR MORBIDITY AFTER MYOCARDIAL-INFARCTION, Lancet, 343(8896), 1994, pp. 499-503
Authors:
DEJAEGERE P
SERRUYS PW
VANES GA
BERTRAND M
WIEGAND V
MARQUIS JF
VROLICX M
PIESSENS J
VALEIX B
KOBER G
RUTSCH W
UEBIS R
Citation: P. Dejaegere et al., RECOIL FOLLOWING WIKTOR STENT IMPLANTATION FOR RESTENOTIC LESIONS OF CORONARY-ARTERIES, Catheterization and cardiovascular diagnosis, 32(2), 1994, pp. 147-156